CiteULike: eisei's immunotherapy [9 articles]

Cancer immunology.

The New England journal of medicine, Vol. 358, No. 25. (19 June 2008), pp. 2704-2715.

by Olivera J. Finn

posted to cancer immunotherapy review by eisei on 2009-03-18 07:37:45 as

along with 5 people tonamswish srp33 nela Amazoness guhjy

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study

Leukemia, Vol. aop, No. current.

by J. M. Rojas, K. Knight, L. Wang, R. E. Clark

posted to abl bcr cml immunotherapy peptide vaccine by eisei on 2008-12-18 00:12:31 as

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

Nature Medicine, Vol. 12, No. 10. (24 September 2006), pp. 1160-1166.

by Ann M. Leen, Doug G. Myers, Uluhan Sili, et al.Helen M. Huls, Heidi Weiss, Kathryn S. Leung, George Carrum, Robert A. Krance, Chung-Che Chang, Jeffrey J. Molldrem, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Catherine M. Bollard

posted to cmv ctl ebv immunotherapy by eisei on 2008-12-09 06:07:46 as

Immunotherapy for myeloid leukemias: current status and future directions

Leukemia, Vol. aop, No. current.

by K. El-Shami, B. D. Smith

posted to aml immunotherapy by eisei on 2008-09-11 19:28:20 as

Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.

Cancer Immunol Immunother, Vol. 54, No. 9. (September 2005), pp. 826-836.

by T. Krüger, O. Schoor, C. Lemmel, et al.B. Kraemer, C. Reichle, J. Dengjel, T. Weinschenk, M. Müller, J. Hennenlotter, A. Stenzl, H. G. Rammensee, S. Stevanović

posted to mass-spectrometry immunotherapy hla ccnd1 by eisei on 2007-01-19 15:19:32 as

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.

Blood, Vol. 107, No. 6. (15 March 2006), pp. 2294-2302.

by C. Berger, M. E. Flowers, E. H. Warren, S. R. Riddell

posted to adoptive allogenic antigen-processing gvhd hsv-tk immunotherapy transplantation by eisei on 2006-11-21 12:04:07 as

Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.

Clin Cancer Res, Vol. 12, No. 19. (1 October 2006), pp. 5801-5808.

by A. Grover, G. J. Kim, G. Lizée, et al.M. Tschoi, G. Wang, J. R. Wunderlich, S. A. Rosenberg, S. T. Hwang, P. Hwu

posted to dc immunotherapy tumor by eisei on 2006-10-10 12:13:19 as

Cancer regression in patients after transfer of genetically engineered lymphocytes.

Science, Vol. 314, No. 5796. (6 October 2006), pp. 126-129.

by R. A. Morgan, M. E. Dudley, J. R. Wunderlich, et al.M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, Z. Zheng, A. Nahvi, C. R. de Vries, L. J. Rogers-Freezer, S. A. Mavroukakis, S. A. Rosenberg

posted to adoptive immunotherapy transfer tumor by eisei on 2006-10-10 12:12:09 as

along with 1 person eghorani

Cancer immunotherapy: moving beyond current vaccines.

Nat Med, Vol. 10, No. 9. (September 2004), pp. 909-915.

by S. A. Rosenberg, J. C. Yang, N. P. Restifo

posted to immunotherapy tumor tumor-evasion by eisei on 2006-09-17 18:20:38 as

	Cancer immunology. [My Copy] The New England journal of medicine, Vol. 358, No. 25. (19 June 2008), pp. 2704-2715. by Olivera J. Finn posted to cancer immunotherapy review by eisei on 2009-03-18 07:37:45 as along with 5 people tonamswish srp33 nela Amazoness guhjy
	Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study [My Copy] Leukemia, Vol. aop, No. current. by J. M. Rojas, K. Knight, L. Wang, R. E. Clark posted to abl bcr cml immunotherapy peptide vaccine by eisei on 2008-12-18 00:12:31 as
	Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals [My Copy] Nature Medicine, Vol. 12, No. 10. (24 September 2006), pp. 1160-1166. by Ann M. Leen, Doug G. Myers, Uluhan Sili, et al.Helen M. Huls, Heidi Weiss, Kathryn S. Leung, George Carrum, Robert A. Krance, Chung-Che Chang, Jeffrey J. Molldrem, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Catherine M. Bollard posted to cmv ctl ebv immunotherapy by eisei on 2008-12-09 06:07:46 as
	Immunotherapy for myeloid leukemias: current status and future directions [My Copy] Leukemia, Vol. aop, No. current. by K. El-Shami, B. D. Smith posted to aml immunotherapy by eisei on 2008-09-11 19:28:20 as
	Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. [My Copy] Cancer Immunol Immunother, Vol. 54, No. 9. (September 2005), pp. 826-836. by T. Krüger, O. Schoor, C. Lemmel, et al.B. Kraemer, C. Reichle, J. Dengjel, T. Weinschenk, M. Müller, J. Hennenlotter, A. Stenzl, H. G. Rammensee, S. Stevanović posted to mass-spectrometry immunotherapy hla ccnd1 by eisei on 2007-01-19 15:19:32 as
	Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. [My Copy] Blood, Vol. 107, No. 6. (15 March 2006), pp. 2294-2302. by C. Berger, M. E. Flowers, E. H. Warren, S. R. Riddell posted to adoptive allogenic antigen-processing gvhd hsv-tk immunotherapy transplantation by eisei on 2006-11-21 12:04:07 as
	Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. [My Copy] Clin Cancer Res, Vol. 12, No. 19. (1 October 2006), pp. 5801-5808. by A. Grover, G. J. Kim, G. Lizée, et al.M. Tschoi, G. Wang, J. R. Wunderlich, S. A. Rosenberg, S. T. Hwang, P. Hwu posted to dc immunotherapy tumor by eisei on 2006-10-10 12:13:19 as
	Cancer regression in patients after transfer of genetically engineered lymphocytes. [My Copy] Science, Vol. 314, No. 5796. (6 October 2006), pp. 126-129. by R. A. Morgan, M. E. Dudley, J. R. Wunderlich, et al.M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, Z. Zheng, A. Nahvi, C. R. de Vries, L. J. Rogers-Freezer, S. A. Mavroukakis, S. A. Rosenberg posted to adoptive immunotherapy transfer tumor by eisei on 2006-10-10 12:12:09 as along with 1 person eghorani
	Cancer immunotherapy: moving beyond current vaccines. [My Copy] Nat Med, Vol. 10, No. 9. (September 2004), pp. 909-915. by S. A. Rosenberg, J. C. Yang, N. P. Restifo posted to immunotherapy tumor tumor-evasion by eisei on 2006-09-17 18:20:38 as

eisei's immunotherapy [9 articles] Export

eisei's tags

pcnsl	78
b-cell	74
antigen-processing	54
cd40-b	48
mhc-class-ii	34
tumor	33
treg	31
cyclin-d1	31
tumor-infiltrating	30
sarcoma	29
cyclin-a	27
epc	25
ctl	24
avidity	23
cd40l	22
lymphoma	22
tolerance	22
eisei	21
dc	21
cyclins	20
cd40	20
ccnd1	19
autophagy	18
cancer	17
breg	17
tumor-evasion	17
ebv	15
haplo	15
il-10	15
review	14
til	13
angiogenesis	13
myeloma	12
aml	12
antigen-presentation	12
tlr	11
rna	11
cmv	11
pp65	11
breast	10
lipid-raft	10
cns	10
rituximab	10
pge2	9
regulatory	9
b-cells	9
mtec	9
foxp3	9
3d-videomicroscopy	9
immunotherapy	9
pcnsl-apbsct	9
tumor-antigen	9
vaccine	8
bcr	8
proteasome	8
mice	8
hypercvad	8
caebv	8
cd8	8
cross-presentation	7
central-torelance	7
colon	7
dendritic	6
elispot	6
amyloidosis	6
hdac	6
chloroquine	6
cpg	6
tap	6
gvhd	6
il-21	6
nela	6
cyclin-a1	6
immunoediting	6
hiv	5
antigen	5
ido	5
transfection	5
selection	5
adoptive	5
cd4	5
mrna	5
transplantation	5
spheroid	5
allogenic	5
ferritin	4
phagocytosis	4
cea	4
thymus	4
leukemia	4
t-cell	4
huvec	4
scd154	4
htert	4
cnsrelapse	4
cd45ra	4
aplasticanemia	4
immunomonitoring	4
cancerstemcells	4
icp47	4
stem	4
us6	4
cyclin-b1	4
immunologicalsynapse	4
til-b	4
il-15	4
chemokine	4
mtx	4
mhc	4
cd25	4
cd1d	3
apc	3
cd107	3
apoptosis	3
fibromodulin	3
vegf	3
autoimmunity	3
antiogenesis	3
hla	3
memory	3
melanoma	3
cxcr4	3
npm1	3
rays	3
rist	3
classification	3
aire	3
hpv	3
cap1-6d	3
lps	3
nk	3
cyclin	3
il-12	3
hsp	3
tolerogenicdc	3
follicular	3
antigen-uptake	3
chop	3
all	3
endothelial	3
tetramer	3
cd38	2
microenviroment	2
ps-341	2
rf-tricom	2
leak	2
tgf-b	2
snp	2
cd200r	2
flowcytometry	2
ihc	2
mthfr	2
wm	2
tlr4	2
immortalization	2
fitc-dextran	2
t2	2
bbb	2
cd200	2
platelet	2
cap1	2
cll	2
naive	2
statin	2
splicing-variant	2
heterocritic	2
synapse	2
vaccination	2
migration	2
ig-transgenic	2
brca1	2
itp	2
dual-targeting	2
epitope	2
endocytosis	2
microenvironment	2
promiscuous	2
fetal	2
inkt	2
pet	2
ra	2
mantle	2
ptld	2
flt3	2
mds	2
nima	2
imc	2
gene	2
ca2	2
mutation	2
expression	2
dna	2
hla-b	2
pemphigoid	2
tgf-beta	2
neuroblastoma	2
mass-spectrometry	2
ova	2
il-7r	2
alloreactive	2
negative	2
ct-antigen	2
b-all	2
intrathecal	2
cxcr5	2
ny-eso-1	1
ifn-g	1
cell-line	1
scd14	1
wt-1	1
nausea	1
embryonic	1
gemcitabine	1
depocyt	1
tetraspanin	1
gingival	1
cheson	1
anergy	1
pha	1
cd9	1
cathepsin	1
mekk1	1
cd23	1
il17	1
rep	1
warfarin	1
tf-1	1
thp-1	1
hsct	1
vector	1
miha	1
primary-cutaneous-alcl	1
fcl	1
relapse	1
tlt	1
zavalin	1
nuclear	1
il-4	1
lytic	1
retroviral	1
lung	1
renal	1
genetherapy	1
fcgamma	1
lag3	1
op9	1
cryptic	1
mpn	1
exercise	1
il-2	1
ptd	1
anticoaglant	1
antibody	1
tat	1
abvd	1
presentation	1
transcriptional	1
cd80	1
cd27	1
l-asparaginase	1
hds	1
thymocyte	1
ab-crystallin	1
cd229	1
cd57	1
mpv	1
cp-870893	1
intra-csf	1
vascularization	1
vaccinia	1
vip	1
regulator	1
wt1	1
transfer	1
idarubicin	1
pr1	1
bcl-2	1
algorithm	1
leucinezipper	1
mhcpeptide-library	1
cd62l	1
rituxan	1
plasmacytoid	1
prediction	1
nf-kb	1
dqb1	1
rhabdomyosarcoma	1
acvbp	1
survey	1
bad	1
occult	1
praffin	1
who	1
9r	1
cd19	1
macroenviroment	1
vomiting	1
cystein	1
brefeldin	1
hsc	1
fas	1
ontak	1
intestinal	1
peg	1
lcl	1
tc	1
light	1
nf-b	1
rapamycin	1
il-7	1
atra	1
il21	1
trimer	1
hematopoietic	1
transgenic	1
nci	1
targeting	1
act1	1
pcalcl	1
tlr9	1
lpd	1
plasma	1
dendritic-like	1
cervical	1
daclizumab	1
gallium	1
nsclc	1
sec61	1
hmb	1
nanotube	1
cytosolic	1
cd123	1
hla-do	1
hsv-tk	1
mri	1
es	1
baff	1
pd-l1	1
nabtt9607	1
web	1
dli	1
u266	1
ewing	1
nejm	1
burkitt	1
igd	1
isoform	1
hla-a2	1
anaergy	1
prame	1
ecfc	1
asct	1
cd83	1
dec-205	1
cells	1
mha	1
report	1
flamsa-ric	1
tce	1
her2	1
pbsct	1
signaling	1
syt-ssx	1
cd70	1
fl	1
40-b	1
trypan-blue	1
hsp70	1
taste-abnormality	1
igg	1
peptide	1
riskfactor	1
cd133	1
endcytosis	1
tlr2	1
hyperosmotic	1
granzyme-b	1
in-situ-rtpcr	1
kir	1
mhc-ii	1
cgvhd	1
baculovirus	1
ecoli	1
muc1	1
c4bp	1
p2x7	1
glucarpidasemtx	1
europeum	1
cacner	1
hyporesponsiveness	1
eda	1
ul495	1
realtime-pcr	1
survivin	1
hd	1
cancer-antigen	1
mage	1
dlbcl	1
tracking	1
adeno	1
brca2	1
t-apc	1
qol	1
ligand	1
cml	1
ovarian	1
lamp1	1
monomer	1
gr-1	1
phagosome	1
post-transplantation-cyclophosphamide	1
pr3	1
mini-cd40l	1
arg	1
hdmtx	1
ccr7	1
rejection	1
galectin-1	1
ct	1
meeting	1
cd28	1
temozolomide	1
hodgkin	1
abl	1
er-phagosome	1
antiplatelet	1
h2o2	1
cd86	1